A new brain monitor could reveal stroke outcomes in minutes

NCT ID NCT07747701

First seen Aug 05, 2026 · Last updated Aug 06, 2026 · Updated 1 time

Summary

This study tests whether a bedside monitoring device, placed on the head right after a mechanical thrombectomy for acute ischemic stroke, can predict which patients will have poor neurological outcomes. The device uses near-infrared spectroscopy to measure brain oxygen levels and blood pressure for about 30 minutes, calculating a cerebral oxygenation index. Researchers will follow 227 patients for up to 90 days to see if this early monitoring can identify those at risk of disability or death, potentially guiding faster, more personalized care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
NIRS-based cerebral oxygenation and blood pressure monitoring device
What this could lead to
If successful, this monitoring approach could help doctors identify stroke patients at risk of poor recovery within minutes after treatment, enabling earlier interventions and better outcomes.
What could go wrong
This is an early-stage diagnostic study, and the monitoring technique may not reliably predict outcomes in all patients. Its accuracy and clinical benefit remain unproven until larger studies confirm the findings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Beijing Shijitan Hospital, Capital Medical University

    RECRUITING

    Beijing, China

  • Central Hospital of Dalian University of Technology (Dalian Municipal Central Hospital)

    NOT_YET_RECRUITING

    Dalian, China

  • The First Affiliated Hospital of Harbin Medical University

    NOT_YET_RECRUITING

    Heilongjiang, China

  • Weifang People's Hospital Affiliated to Weifang Medical University

    NOT_YET_RECRUITING

    Shandong, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.